Antiphospholipid Syndrome: An Antibody‐Mediated Disease With Emerging Therapeutic Opportunities
Arthritis &Rheumatology, EarlyView.Antiphospholipid syndrome (APS) is an autoimmune thromboinflammatory disease characterized by vascular thrombosis, pregnancy morbidity, and other manifestations driven by antiphospholipid autoantibodies. In this review, we present a clinical case that illustrates some diagnostic and therapeutic challenges in managing severe, relapsing APS ...
Thalia G. Newman, Jason S. Knight
wiley +1 more source
Valvular Heart Disease: Geography Is Destiny! [PDF]
JACC AdvBakaeen FG, Jaber W, Kaur S.
europepmc +1 more source
Cardiac Amyloidosis and Valvular Heart Disease. [PDF]
J Clin Med, 2023 Duca F +5 more
europepmc +1 more source
AII-9 Valve replacement as a second operation for patients with acquired valvular heart disease
, 1983 風間 繁 +6 more
openalex +2 more sources
Further Cases of Valvular Heart Disease Associated with Fenfluramine–Phentermine [PDF]
, 1997 David J. Graham, Lanh Green
openalex +1 more source
What does it mean? Translating anatomical language to engage public audiences
Anatomical Sciences Education, EarlyView.Abstract The language of anatomy, with its roots in Ancient Greek and Roman languages, is complex and unfamiliar to many. Its complexity creates a significant barrier to public knowledge and understanding of anatomy—many members of the public find themselves asking “what does it mean?”, and this can manifest as poor health literacy and outcomes.
Kat A. Sanders, Adam M. Taylor
wiley +1 more source
A New Benchmark for Modern Management of Valvular Heart Disease: The Whole-Life Cycle Management System. [PDF]
JACC AsiaWang Y +11 more
europepmc +1 more source
Surgical treatment for tricuspid valve regurgitation combining with acquired valvular heart disease.
, 1988 Nobuyuki Fujii
openalex +2 more sources
Valvular heart disease in systemic lupus erythematosus: another symptom of the disease or a hallmark of secondary antiphospholipid syndrome? [PDF]
, 1997 Jacek Musiał
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims “Triple whammy” (TW) refers to the concomitant use of diuretics, renin‐angiotensin‐aldosterone system inhibitors (RAASI) and non‐steroidal anti‐inflammatory drugs (NSAIDs). The aim of this article is to analyse the association between TW exposure and acute kidney injury (AKI), among other morbi‐mortality outcomes.
Dulce María Calvo +4 more
wiley +1 more source